Transcription analysis reveals Ajuba as a key gene linked to muscle mass in aging, suggesting diet can modify sarcopenia risks.
Sarcopenia, the age-related decline in skeletal muscle mass and function, is a growing health concern in aging populations. Nutritional interventions are increasingly recognized for their therapeutic potential; however, molecular biomarkers that reflect their efficacy are limited. To identify nutrition-responsive genes relevant to sarcopenia, we performed transcriptomic profiling of gastrocnemius muscle from mature and middle-aged mice. Aging-associated differentially expressed genes (DEGs) were filtered based on expression levels and correlation with muscle mass. Functional food interventions, including high- and low-molecular-weight collagen hydrolysates and allulose, were applied, and effect scores were calculated to assess transcriptomic responsiveness. Ajuba, a gene involved in cytoskeletal regulation and tissue remodeling, was significantly downregulated in middle-aged mice, consistent with aging-associated muscle decline. Dietary supplementation restored Ajuba expression across all intervention groups, with the strongest effect observed in the high-molecular-weight collagen group. Ajuba expression also showed strong positive correlations with tibialis anterior mass, hindlimb thickness, and muscle-to-fat ratio. Ajuba was identified as a nutritionally modifiable gene with strong associations to muscle phenotype and dietary response. These findings support Ajuba as a transcriptomic biomarker and potential molecular target for precision nutrition strategies aimed at preventing or mitigating sarcopenia.
No takes yet. Share an insight, caveat, or question.
Han et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: